Boston Keratoprosthesis: expanding the boundaries
Main Article Content
Abstract
The Boston Keratoprosthesis (KPro) has enjoyed good results in the adult population, particularly through its rapid clearing of the visual axis, its excellent retention rate, and the paucity of postoperative complications in recent years. Design modifications, enhanced surgical technique, and improved postoperative management have made keratoprosthesis surgery a reality in the twenty-first century and an excellent alternative for poor PK candidates.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Rezende RA, Uchoa UC, Uchoa R et al. Congenital corneal opacities in a cornea referral practice. Cornea 2004;23:565-70.
Aasuri MK, Garg P, Gokhle N, Gupta S. Penetrating keratoplasty in children. Cornea 2000;19:140-4.
Comer RM, Daya SM, O'Keefe M. Penetrating keratoplasty in infants. J AAPOS 2001;5:285-90.
Michaeli A, Markovich A, Rootman DS. Corneal transplants for the treatment of congenital corneal opacities. J Pediatr Ophthalmol Strabismus 2005;42:34-44.
McClellan K, Lai T, Grigg J, Billson F. Penetrating keratoplasty in children: visual and graft outcome. Br J Ophthalmol. 2003;87:1212-4.
Yang LL, Lambert SR, Lynn MJ, et al. Long-term results of corneal graft survival in infants and children with Peters anomaly. Ophthalmology 1999;106:833-48.
Dana MR, Moyes AL, Gomes JAP, et al. The indications for and outcome in pediatric keratoplasty. Ophthalmology 1995;102:1129-38.
Dana MR, Schaumberg DA, Moyes AL, et al. Corneal transplantation in children with Peters anomaly. Ophthalmology 1987;104:545-6.
Ma JJ, Graney JM, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin 2005;45:49-59.
Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Dohlman Keratoprosthesis: current techniques. Cornea 2006:25:656-62.
Dohlman CH, Harissi-Dagher M, Khan BF, Sippel KC, Aquavella J, Graney JM. Introduction to the use of the Boston Keratoprosthesis. Expert Review of Ophthalmology 2006;1:41-8.
Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol 2011;46:164-8.
Bothelo PJ, Congon WG, Handa JT, Akpek EK. Keratoprosthesis in high-risk pediatric corneal transplantation: first 2 cases. Arch Ophthalmol 2006;124:1356-7.
Aquavella JV, Gearinger MD, Akpek EK, McCormick GJ. Pediatric keratoprosthesis. Ophthalmology 2007;114:989-94.
Khan B, Harissi-Dagher M, Dohlman CH. Chapter 67, Keratoprosthesis. In: Albert DM, Miller JW, eds., Azar DT, Blodi BA, associate eds. Albert and Jakobiec’s Principles and Practice in Ophthalmology. 3rd ed. Philadelphia, PA; Edinburgh: Saunders/Elsevier, 2008.
Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. The importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. 2007;26:564-8.
Khan BF, Harissi -Dagher M, Dohlman CH. Advances in Boston Keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin 2007;47(2):61-71.
Harissi-Dagher M, Dohlman CH. The Boston Keratoprosthesis. Contemp Ophthalmol 2006;5:1-8.
Harissi-Dagher M, Colby K. Anterior segment dysgenesis: Peters anomaly and sclerocornea. Int Ophthalmol Clin 2008;48(2):35-42.
Haddadin R, Dohlman CH. Keratoprosthesis in congenital hereditary endothelial dystrophy after multiple failed grafts. Epub September 23, 2011. Digital J Ophthalmol 2011:17(3).
Fernandez MM, Buckley EG, Afshari NA, Descemet stripping automated endothelial keratoplasty in a child. J AAPOS 2008;12:314-6.